Healthcare

M&A

Roche Elbows into Weight-Loss Drug Market Via M&A

Roche agreed Monday to acquire anti-obesity drug developer Carmot Therapeutics for an appetizing $3.1 billion.

Deep Dives more
(Photo Credit: Heather Gill/Unsplash)
M&A

Bet, Bet, Bet on the Home Team: How Legalized Gambling has Reshaped the Business of Sports

(Photo Credit: Alexander Grey/Unsplash)
M&A

Don’t Know Much About Money: With More Americans relying on TikTok for financial advice, what could go wrong?